ANGPTL3 Hu ELISA referenced in a major study

We are so proud that BioVendor's ANGPTL3 Human ELISA participated in a major study (1,493 individuals presenting with myocardial infarction and 3,232 controls).

For more details about BioVendor's ANGPTL3 please visit product page: ANGPTL3 Human ELISA

Source: Stitziel NO, Khera AV, Wang X, et al. ANGPTL3 Deficiency and Protection Against Coronary Artery Disease. J Am Coll Cardiol. 2017;69(16):2054–2063.